Maverix Medical Acquires Cirrus Bio

March 29, 2024

Maverix Medical, a lung cancer platform backed by Ajax Health, KKR, and Hologic, has acquired Cirrus Bio to form the foundation of a new diagnostics division, Maverix Dx. Cirrus Bio's multiomic diagnostic capabilities and its founders, David Mallery (CEO) and Scott Morris (CSO), will lead Maverix Dx as the platform pursues further diagnostic product development and M&A.

Buyers
Maverix Medical, Ajax Health, KKR, Hologic, Inc.
Targets
Cirrus Bio
Platforms
Maverix Medical
Industry
Biotechnology
Location
United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.